Breast cancer drug shows potential for rare appendix cancer

Researchers at University of California San Diego School of Medicine found an FDA-approved drug used to treat breast cancer has the potential to be an effective therapeutic for a specific type of appendix cancer.

The clinical trial results, publishing in the October 16, 2024 online edition of…

Continue Reading


Posted

in

by

Tags:

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *